Picture EBD Group BIO-Europe 2024 Stockholm from 14 Sep 650x100px

Organisation › Details

GSK (Group)

https://www.gsk.com

GlaxoSmithKline- one of the world's leading research-based pharmaceutical and healthcare companies - is committed to improving the quality of human life by enabling people to do more, feel better and live longer. *

	Start	2000-12-27 merged
	Predecessor	Glaxo Wellcome (Group)
	Industry	pharmaceutical
	Industry 2	vaccine
	Person	Walmsley, Emma (GSK 201704– CEO before CEO of GSK Consumer Healthcare division joined GSK 2010 from L’Oréal)
	Person 2	Mackay, Iain (GSK 201901– CFO before HSBC + GE + Schlumberger Dowell + Price Waterhouse)

	Region	London, Greater London
	Country	United Kingdom (GB)
	Street	980 Great West Road
	City	TW8 9GS Brentford, Middlesex
	Tel	+44-0-20-8047-5000
		Address record changed: 2020-12-02

Basic data	Employees	n. a.
	Currency	GBP
	Annual sales	29,324,000,000 (turnover, consolidated (2022) 2022-12-31)
	Profit	15,621,000,000 (2022-12-31)
	Cash	3,723,000,000 (2022-12-31)

		* Document for »About Section«:

		Record changed: 2024-08-14

Picture Berlin Partner Voices Tim Huse BIH Digital Health 650x200px

More documents for GSK (Group)

[1] CureVac N.V.. (7/3/24). "Press Release: GSK and CureVac to Restructure Collaboration into New Licensing Agreement". London, Tübingen & Boston, MA....
[2] GSK plc. (6/6/24). "Press Release: GSK Accelerates Oligonucleotide Platform and Pipeline Medicines with Acquisition of Elsie Biotechnologies [For media and investors only]". London....
[3] CureVac N.V.. (5/28/24). "Press Release: CureVac Announces Dosing of First Participant in a Phase 2 Study in Seasonal Influenza; Development in Collaboration with GSK". Tübingen & Boston, MA....
[4] BioVersys AG. (5/7/24). "Press Release: BioVersys Announces Expansion of Strategic Collaboration with GSK and Extension of its Series C Round by CHF 12.3 Million". Basel....
[5] GSK plc. (1/9/24). "Press Release: GSK Enters Agreement to Acquire Aiolos Bio"....
[6] Forbion Capital Partners. (1/9/24). "Press Release: Forbion Portfolio Company Aiolos Bio, Inc. (Aiolos) to Be Acquired by GSK for up to $1.4 Billion"....
[7] CureVac N.V.. (1/5/24). "Press Release: CureVac Announces Positive Phase 2 Interim Data from COVID-19 Vaccine Development Program in Collaboration with GSK Providing Strong Validation of Proprietary Technology Platform". Tübingen & Boston, MA....
[8] GSK plc. (12/20/23). "Press Release: GSK Enters Exclusive License Agreement with Hansoh for HS-20093". London....
[9] Aiolos Bio, Inc.. (10/24/23). "Press Release: Aiolos Bio Launches with $245 Million Series A Investment to Advance Development of Novel, Phase 2-Ready TSLP Antibody". San Francisco, CA & London....
[10] GSK plc. (10/20/23). "Press Release: GSK Enters Exclusive License Agreement with Hansoh for HS-20089". London....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]